Clinical Trial Update: A Study to Assess PK, Safety and Efficacy of HSK47977 Tablets in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

This Phase 1 trial is evaluating pharmacokinetics, safety, and preliminary efficacy of HSK47977 tablets in adults with relapsed or refractory Non-Hodgkin lympho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• HSK47977

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: NHL | Phase 1 | Status: RECRUITING